Lokshina L A, Bylinkina V S, Samoĭlova R S, Gureeva T A, Golubeva N V, Polianskaia A M
Biokhimiia. 1993 Jul;58(7):1104-15.
Immunological and biochemical study of lymphoid cells obtained from 20 patients with various forms of lymphoproliferative disorders has been carried out. It was found that different phenotypes of lymphoid cells at various stages of differentiation have different activity levels of dipeptidyl aminopeptidase IV (DAP IV), plasminogen activator (urokinase type) and cathepsins B + L. The highest proteinase activity values were found in the lysates of just those leukemic T-cells whose phenotypes corresponded to the initial stages of thymic differentiation or to activated T-cells. The 10 times lowered activity was found in the cell phenotypes of mature T-helpers and T-suppressors, and the activity of the both was at virtually the same level. In lymphoid cells of the B-lineage (from pre-B to mature B-lymphocytes) the proteinase activities did not differ essentially: they were 2 to 3 times lower than in the lymphoid progenitors. It was suggested that the regulated activity changes in some proteinases occur during differentiation along the T- or B-pathways. It is likely that the increases in DAP IV and cathepsins B + L activities are associated with the activation of mature lymphoid T- and B-cells. No direct correlation was found between the activity of either proteinase and the expression of any of the surface markers under study.
对20例患有各种形式淋巴增生性疾病的患者的淋巴细胞进行了免疫学和生化研究。结果发现,处于不同分化阶段的淋巴细胞的不同表型具有不同水平的二肽基氨基肽酶IV(DAP IV)、纤溶酶原激活剂(尿激酶型)和组织蛋白酶B + L活性。蛋白酶活性最高值出现在那些白血病T细胞的裂解物中,其表型与胸腺分化的初始阶段或活化的T细胞相对应。在成熟T辅助细胞和T抑制细胞的细胞表型中发现活性降低了10倍,且两者的活性几乎处于同一水平。在B系淋巴细胞(从前B细胞到成熟B淋巴细胞)中,蛋白酶活性基本没有差异:它们比淋巴祖细胞低2至3倍。有人提出,在沿T或B途径分化过程中,某些蛋白酶的活性会发生有调控的变化。DAP IV和组织蛋白酶B + L活性的增加可能与成熟淋巴细胞T和B细胞的活化有关。在所研究的任何一种蛋白酶活性与任何表面标志物的表达之间均未发现直接相关性。